Connect your AI

Quest Diagnostics DGX Operating Cash Flow

Operating Cash Flow at other companies

Myriad GeneticsMYGN

-$15.7M+3.7%

Labcorp HoldingsLH

$191.5M+935%

Opko HealthOPK

-$19.31M+44.1%

NeoGenomicsNEO

-$8.14M+67.9%

Exagen Inc.XGN

-$10.42M+2.4%

Personalis, Inc.PSNL

-$22.48M-25.1%

Other financials

Income statement

Revenue$2.9B+9.2%

Gross profit$942.0M+9.2%

Operating income$399.0M+15.3%

Net income$252.0M+14.5%

EPS (diluted)$2.24+15.5%

Balance sheet

Cash & equivalents$393.0M+109%

Total debt$6.4B-2.5%

Total equity$7.4B+6.3%

Total assets$16.7B+5.5%

Cash flow

CapEx$114.0M-2.6%

Free cash flow$164.0M-16.8%

Valuation

Market cap$23.46B+20.8%

Enterprise value$29.48B+15.7%

P/E22.9×+2.5×

P/S2.1×+0.2×

Profitability

Gross margin33.2%+0.4pp

Operating margin14.3%+0.6pp

Net margin9.1%+0.2pp

FCF margin11.8%+1.4pp

Returns & leverage

Return on equity14.3%+0.9pp

Debt / equity0.9×-0.1×

Current ratio1.2×-0.3×

Where this comes from

Reported directly by Quest Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Quest Diagnostics’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quest Diagnostics's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Quest Diagnostics's operating cash flow?: Quest Diagnostics (DGX) reported operating cash flow of $278M in Q1 2026.
How has Quest Diagnostics's operating cash flow changed year-over-year?: Quest Diagnostics's operating cash flow decreased by 11.5% year-over-year, from $314M to $278M.
What is the long-term trend for Quest Diagnostics's operating cash flow?: Over 4 years (2021 to 2025), Quest Diagnostics's operating cash flow has grown at a -4.1% compound annual growth rate (CAGR), from $2.23B to $1.89B.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.